Recombinant zoster vaccine vs placebo
Dropouts ‐ did not receive second dose Clinical or laboratory criteria · healthy older adults aged ≥ 60 years
Recombinant zoster vaccine probably leads to higher dropouts ‐ did not receive second doseClinical or laboratory criteria compared with placebo (moderate certainty).
1 finding from 1 review
- RR 1.25 [1.13, 1.39]2 studies · 29311 participantsModerate